FSB Premier Wealth Management’s GSK GSK Stock Holding History

FSB Premier Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$257K	Buy	4,909 +448	+10%	+$23.7K	0.07%	226
2026 Q1	$246K	Sell	4,461 -357	-7%	-$19.3K	0.08%	224
2025 Q4	$236K	Sell	4,818 -122	-2%	-$5.69K	0.08%	214
2025 Q3	$213K	Buy	+4,940	New	+$193K	0.07%	219
2022 Q1	–	Sell	-436	Closed	-$24K	–	315
2021 Q4	$24K	Buy	+436	New	+$22.7K	0.01%	324

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

FSB Premier Wealth Management's GSK Position: Q2 2026 in Review

FSB Premier Wealth Management increased its GSK (GSK) stake by 10% in Q2 2026, buying an estimated $23.7K and bringing the position to 4,909 shares worth $257K. The position accounts for 0.07% of the portfolio, ranked #226.

FSB Premier Wealth Management first reported a position in GSK in Q4 2021 and has held it in 5 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

FSB Premier Wealth Management held 4,909 shares of GSK worth $257K as of Q2 2026.
FSB Premier Wealth Management bought 448 GSK shares in Q2 2026, an estimated $23.7K.
GSK made up 0.07% of FSB Premier Wealth Management's portfolio in Q2 2026, its #226 holding.
FSB Premier Wealth Management first reported a position in GSK in Q4 2021 and has held it in 5 quarters since.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on FSB Premier Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.